Methods for Adding Adapters to Nucleic Acids and Compositions for Practicing the Same
Abstract
Provided are methods of adding adapters to nucleic acids. The methods include combining in a reaction mixture a template nucleic acid, a template switch oligonucleotide, a polymerase, and dNTPs. The reaction mixture components are combined under conditions sufficient to produce a product nucleic acid that includes the template nucleic acid and the template switch oligonucleotide each hybridized to adjacent regions of a single product nucleic acid including a region polymerized from the dNTPs by the polymerase. The methods further include attaching sequencing platform adapter constructs to ends of the product nucleic acid or a derivative thereof. Aspects of the invention further include compositions and kits.
Claims
exact text as granted — not AI-modified1 - 39 . (canceled)
40 . A composition comprising:
a template nucleic acid; a template switch oligonucleotide; and a sequencing platform adapter construct, wherein the template nucleic acid and template switch oligonucleotide are each hybridized to adjacent regions of a nucleic acid strand.
41 . The composition of claim 40 , wherein the sequencing platform adapter construct comprises a nucleic acid domain selected from the group consisting of: a domain that specifically binds to a surface-attached sequencing platform oligonucleotide, a sequencing primer binding domain, a barcode domain, a barcode sequencing primer binding domain, a molecular identification domain, and combinations thereof.
42 . The composition of claim 40 , wherein the template switch oligonucleotide includes a 3′ hybridization domain.
43 . The composition of claim 40 , wherein the composition is present in a reaction tube.
44 - 50 . (canceled)
51 . The composition of claim 40 , wherein the sequencing platform adaptor construct is at a 5′ end of the nucleic acid strand.
52 . The composition of claim 40 , wherein the template switch oligonucleotide comprises the sequencing platform adaptor construct.
53 . The composition of claim 42 , wherein the 3′ hybridization domain comprises a homo-trinucleotide.
54 . The composition of claim 42 , wherein the 3′ hybridization domain comprises a hetero-trinucleotide.
55 . The composition of claim 40 , wherein the template switch oligonucleotide comprises a modification that prevents a polymerase from switching from the template switch oligonucleotide to a different template nucleic acid.
56 . The composition of claim 55 , wherein the modification is selected from the group consisting of: an abasic lesion, a nucleotide adduct, an iso-nucleotide base, and combinations thereof.
57 . The composition of claim 40 , wherein the template switch oligonucleotide comprises one or more modifications.
58 . The composition of claim 40 , wherein the one or more modifications comprise nucleotide analogues.
59 . The composition of claim 40 , wherein the template switch oligonucleotide comprises a linkage modification, an end modification, or both.
60 . The composition of claim 40 , wherein the template switch oligonucleotide comprises one or more exo-sample nucleotides.
61 . The composition of claim 40 , wherein the template nucleic acid is a template deoxyribonucleic acid (DNA).
62 . The composition of claim 40 , wherein the template nucleic acid is a template ribonucleic acid (RNA).
63 . A double stranded nucleic acid comprising a template derived region flanked by first and second sequencing platform adaptor constructs, wherein the double stranded nucleic acid further comprises a template switch oligonucleotide domain positioned between the first sequencing platform adaptor construct and the template derived region.
64 . The double stranded nucleic acid of claim 63 , wherein the template is a template deoxyribonucleic acid (DNA).
65 . The double stranded nucleic acid of claim 63 , wherein the template a template deoxyribonucleic acid (RNA).
66 . The double stranded nucleic acid of claim 63 , wherein the first and second sequencing platform adapter constructs each comprises a nucleic acid domain selected from the group consisting of: a domain that specifically binds to a surface-attached sequencing platform oligonucleotide, a sequencing primer binding domain, a barcode domain, a barcode sequencing primer binding domain, a molecular identification domain, and combinations thereof.
67 . The double stranded nucleic acid of claim 63 , wherein the template switch oligonucleotide domain comprises a homo-trinucleotide.
68 . The double stranded nucleic acid of claim 63 , wherein the template switch oligonucleotide domain comprises a hetero-trinucleotide.Join the waitlist — get patent alerts
Track US2021381042A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.